Market Brief — July 16, 2026

US equities weakened, with the S&P 500 (SPX) down 0.51%, the Nasdaq (^IXIC) off 1.47%, and the Dow (DJIA) lower by 0.20% as technology underperformed and the VGT ETF fell 1.94%. European markets were mixed; the FTSE 100 (UKX) gained 0.54% while the DAX (DAX) slipped 0.34% and the CAC 40 (FRA40) inched down 0.05% following UK GDP data showing only 0.1% month-on-month growth in May. In Asia, the Hang Seng (HSI) rose 1.33% but the Nikkei 225 (NKY) declined 2.79%, highlighting diverging regional risk appetite.

Hoisington Investment Management shifted from a long-standing bullish stance on US Treasuries to a bearish outlook, arguing that larger fiscal deficits and rising capital demand should push inflation and long-term yields higher over time. UK data showed real GDP up 0.1% month-on-month in May 2026 after a 0.1% fall in April, with 0.3% services growth offsetting production and construction declines of 0.5% and 0.8%, and three-month GDP rising 0.7% versus the prior three months. The economic calendar highlighted the upcoming US Retail Sales MoM report for June, where consensus ranged from 0.2% to 0.3% and the forecast stood at 0.5% versus a previous 0.9% gain.

Netflix (NFLX) reported Q2 2026 revenue of $12.56 billion and net income of $3.4 billion (EPS $0.80); softer Q3 guidance of $12.86 billion and narrowed full-year revenue guidance of $51.0–$51.4 billion left shares more than 7% lower, including a 7.26% drop on the day and a move to a 52-week low. Abbott (ABT) posted Q2 revenue of $12.59 billion and adjusted EPS of $1.31, raised its 2026 EPS guidance to $5.45–$5.60 from $5.38–$5.58, and its stock jumped after diagnostics revenue surged 42.3% and medical devices sales rose about 9%. Flows and positioning were in focus as EWY took in over $1.9 billion across two days of inflows while SK Hynix ADRs traded at a 27–51% premium to Korea-listed shares, XAU/USD hovered near $3,992 after an intraday low around $3,959 with markets pricing a roughly 73–75% chance of a Fed rate hike by December 2026, and SpaceX shares slid roughly 20% in July toward their $135 IPO price amid about 185 million shares short, representing around $25 billion in bearish wagers. Medtronic completed its acquisition of SPR, expanding access to minimally invasive, non-opioid treatments for chronic and acute pain, while Baker Hughes closed its purchase of Chart Industries and Trifork Group completed a partial divestment of Trifork Labs portfolio assets to Verdane linked to a proposed extraordinary dividend of DKK 3.00 per share. Announced deals included Instacart's acquisition of Arpalus to advance real-time shelf intelligence in grocery retail, Forum Markets' approximately $12 million aircraft engine purchase as part of an expansion to five engines, Summit Professional Education's acquisition of Kids Bowel & Bladder, Brunner's purchase of AdSkate, and Palomino Laboratories' binding LOI to acquire Vega Links.